BAXTER A/S
CVR: 72246012
BAXTER A/S demonstrates a stable financial position with a solid equity base of 43,188,851 DKK in 2024, although it has experienced a notable decline in revenue from 53,718,413 DKK in 2023 to 19,918,485 DKK in 2024. Profitability remains strong, with a profit of 6,024,562 DKK in 2024, indicating healthy margins despite the revenue drop. The company has shown consistent profit levels over the past few years, but the significant decrease in revenue raises concerns about its market position and operational challenges. Overall, BAXTER A/S maintains a robust equity position, which could provide a buffer against potential downturns in the competitive medical supplies industry.
AI-generated summary
Overview
Details
Contact
Purpose
Selskabets formål er handel med og produktion af medicin og farmaceutiske behandlingsmidler og produkter til brug indenfor medicinalindustrien samt anden dermed i forbindelse stående virksomhed
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 19.9 mio. | 6 mio. | 70.9 mio. | 43.2 mio. | 15 | |
History
Ownership
Management
Directors
Board
Production units (1)
Similar companies
Companies in the same industry and area